GE Healthcare has identified radiopharmaceuticals as a growth driver for the company and Japan as a key market.

NMP's product range includes GE HealthCare radiopharmaceuticals, which are essential for imaging in cardiology, oncology, and ...

GE HealthCare will acquire the remaining 50% stake in Nihon Medi-Physics, enabling it to fully own the Japanese ...

智通财经获悉，GE HealthCare (GEHC.US)已同意从Sumitomo Chemical手中收购Nihon Medi-Physics (NMP)剩余50%的股份，旨在获得这家日本放射性制药公司的完全所有权。该公司预计该交易将于2025年初完成。该交易预计将对GE HealthCare第一年的调整后每股收益产生中性影响，此后将增加收益。

智通财经获悉，GE HealthCare(GEHC.US)已同意从Sumitomo Chemical手中收购Nihon ...

器械之家医疗器械媒体报道先锋分享专业医疗器械知识关注 来源：器械之家，未经授权不得转载，且24小时后方可转载12月2日，GE医疗宣布将从住友化学收购日本领先放射性药物公司Nihon ...

GE HealthCare (Nasdaq: GEHC) has agreed to acquire full ownership of Nihon Medi-Physics Co., Ltd (NMP), by purchasing from ...

The Chicago-based medical device and technology giant plans to purchase the remaining 50% stake in Nihon Medi-Physics.

GE HealthCare has owned half of Nihon Medi-Physics since 2004, when former parent company General Electric obtained the stake ...

Physics, maker of diagnostic radiopharmaceuticals and molecular imaging agents. | GE HealthCare plans to take full control of ...

GE HealthCare Technologies Inc. (GEHC) announced its agreement to acquire the remaining 50% stake in Nihon Medi-Physics Co., Ltd or ...

GE HealthCare (GEHC) has agreed to acquire full ownership of Nihon Medi-Physics, by purchasing from Sumitomo Chemical the 50% stake it does not ...